Holder evidence
12
SEC ownership of Tracon Pharmaceuticals, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001394319.
Largest current holder
Opaleye Management Inc.
13D/G signal
—
Latest evidence
12 Mar 2024
- Ownership evidence mix
- 3/4/5
- Largest current holder
- Opaleye Management Inc.
- Latest evidence date
- 12 Mar 2024
- CIK
- 0001394319
- Location
- San Diego, CA
Ownership snapshot
1 fact
Issuer identity
2 facts
Ownership snapshot
Top shareholders of Tracon Pharmaceuticals, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Largest current holder
Opaleye Management Inc.
13D/G signal
—
Evidence rows
12
Latest as of
12 Mar 2024
3/4/5
Highest disclosed value: $54,175
Showing 1-8 of 12 holder rows.
Quick read
Charles Theuer has the largest disclosed position value at $54.2K.
Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Disclosed position value
Top 3
Charles Theuer
$54.2K
Scott B. Brown
$3.5K
Bonne J. Adams
$1.3K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Opaleye Management Inc. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
2,013,999 shares
|
— | 10 Nov 2023 |
| Charles Theuer |
3/4/5
PRESIDENT AND CEO, Director
|
—
mixed-class rows
|
$54,175
924,717 shares
mixed-class rows
|
— | 12 Mar 2024 |
| Scott B. Brown |
3/4/5
CHIEF FINANCIAL OFFICER
|
—
mixed-class rows
|
$3,460
249,928 shares
mixed-class rows
|
— | 12 Mar 2024 |
| Bonne J. Adams |
3/4/5
Chief Operating Officer
|
—
mixed-class rows
|
$1,255
103,267 shares
mixed-class rows
|
— | 01 Feb 2023 |
| Mark C. Wiggins |
3/4/5
Chief Business Officer
|
—
class O/S missing
|
—
80,000 shares
|
— | 28 Jan 2022 |
| Carol C. Lam |
3/4/5
Director
|
—
class O/S missing
|
—
18,000 shares
|
— | 19 Apr 2023 |
| J. Rainer Twiford |
3/4/5
Director
|
—
class O/S missing
|
—
18,000 shares
|
— | 19 Apr 2023 |
| Lisa Johnson-Pratt |
3/4/5
Director
|
—
class O/S missing
|
—
18,000 shares
|
— | 19 Apr 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 01 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-13 of 13 reporting-owner rows connected to Tracon Pharmaceuticals, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
13
Largest current holder
Charles Theuer
Net 12M change
$0
Latest report
07 May 2024
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Charles Theuer | PRESIDENT AND CEO, Director | $54,175 | Mixed | 12 Mar 2024 | ||
| Scott B. Brown | Chief Financial Officer | $3,460 | Mixed | 12 Mar 2024 | ||
| Bonne J. Adams | Chief Operating Officer | $1,255 | Mixed | 01 Feb 2023 | ||
| Opaleye Management Inc. | 10%+ Owner | Mixed | 10 Nov 2023 | |||
| Mark C. Wiggins | Chief Business Officer | Mixed | 28 Jan 2022 | |||
| J. Rainer Twiford | Director | Mixed | 19 Apr 2023 | |||
| Lisa Johnson-Pratt | Director | Mixed | 19 Apr 2023 | |||
| Carol C. Lam | Director | Mixed | 19 Apr 2023 | |||
| Saundra L. Pelletier | Director | Mixed | 19 Apr 2023 | |||
| David E. Lazar | Chief Business Dev Officer | Mixed | 07 May 2024 | |||
| William R. Larue | Director | Mixed | 19 Apr 2023 | |||
| Martin A. Mattingly | Director | Mixed | 19 Apr 2023 | |||
| Stephen T. Worland | Director | Mixed | 19 Apr 2023 |
Recent insider transactions for Tracon Pharmaceuticals, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.